// App-Quantinova.ai

17 : Analysis of a hypertrophic cardiomyopathy cohort in a regional inherited cardiac conditions service with a focus on eligibility for novel cardiac myosin inhibitor therapies

Researchers

Presenter

  • Leo Mansell

Principal Investigators

  • Rufus OReilly

  • Luigi Vennetucci

  • Matthew J Daniels

Medical Centers

  • Manchester Royal Infirmary, Manchester University NHS Foundation Trust; UK, Manchester Royal Infirmary, Oxford Rd, Manchester, MAN M13 9WL, United Kingdom

  • Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester

  • Manchester Heart Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust; UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Hypertrophic cardiomyopathy

  • Angina

  • Left ventricular outflow tract obstruction

Biomarkers

  • Myosin Heavy Chain 8

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A